JUBLPHARMA.BOJUBLPHARMA.BOBSE

Revenue (LTM)

$72.3B

+7.9% YoY

Net Income (LTM)

$8.4B

+988.7% YoY

Free Cash Flow

$-435M

Revenue CAGR (5Y)

+3.9%

Marginsdeclining

FCFTurned negative

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	60,985	61,302↑0.5%	62,817↑2.5%	67,029↑6.7%	72,345↑7.9%
Gross Profit	45,625	46,422↑1.7%	42,001↓9.5%	43,516↑3.6%	46,988↑8.0%
Operating Income	26,186	25,683↓1.9%	19,850↓22.7%	20,643↑4.0%	23,557↑14.1%
Net Income	8,359	4,139↓50.5%	-610↓114.7%	771↑226.4%	8,394↑988.7%
EBITDA	14,676	10,663↓27.3%	6,463↓39.4%	7,933↑22.7%	10,477↑32.1%
EPS Diluted	36.05	26.00↓27.9%	-3.83↓114.7%	4.86↑226.9%	52.85↑987.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	5,020	9,803↑95.3%	10,139↑3.4%	9,539↓5.9%	10,888↑14.1%
Total Current Assets	29,525	35,092↑18.9%	37,624↑7.2%	38,761↑3.0%	35,772↓7.7%
Total Assets	89,181	99,909↑12.0%	111,567↑11.7%	115,485↑3.5%	127,564↑10.5%
Total Current Liabilities	10,488	15,916↑51.7%	17,724↑11.4%	18,890↑6.6%	21,646↑14.6%
Total Liabilities	41,766	46,745↑11.9%	57,649↑23.3%	61,274↑6.3%	65,178↑6.4%
Total Equity	47,415	53,186↑12.2%	53,993↑1.5%	54,339↑0.6%	62,549↑15.1%
Total Debt	28,296	31,920↑12.8%	36,768↑15.2%	36,640↓0.3%	27,310↓25.5%
Net Debt	23,316	22,117↓5.1%	26,628↑20.4%	27,101↑1.8%	16,422↓39.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	17,843	8,375↓53.1%	6,607↓21.1%	9,713↑47.0%	10,721↑10.4%
Capital Expenditure	-5,275	-6,000↓13.7%	-8,145↓35.7%	-8,977↓10.2%	-11,156↓24.3%
Free Cash Flow	12,568	2,376↓81.1%	-1,538↓164.7%	736↑147.9%	-435↓159.1%
Stock-Based Comp	2	11↑356.9%	37↑229.2%	85↑129.7%	43↓49.4%
Net Change in Cash	-7,289	4,819↑166.1%	301↓93.8%	-575↓291.0%	1,319↑329.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance